# Bleeding Risk of Central Venous Catheterization in Adults: A Systematic Review and Meta-analysis

**Authors:** Nicola Mumoli, Lucia Colavolpe, Piero Tarantini, Aldo Fici, Stefania Marengo, Riccardo Capra, Francesco Cei

PMC · DOI: 10.1055/a-2770-0060 · TH Open: Companion Journal to Thrombosis and Haemostasis · 2025-12-29

## TL;DR

This study finds that central venous catheterization in adults with bleeding risks is generally safe, with ultrasound guidance and specific transfusion strategies reducing complications.

## Contribution

The study provides updated evidence on bleeding risks and effective preventive strategies for CVC placement in high-risk adults.

## Key findings

- Major bleeding occurred in 0.57% of CVC procedures, and minor bleeding in 8.1%.
- Ultrasound guidance significantly reduced complications compared to the landmark technique.
- Platelet transfusion was effective only when platelet counts were below 30 × 10^9/L.

## Abstract

Central venous catheter (CVC) insertion is a cornerstone procedure in hospitalized and critically ill adults. However, many patients requiring CVCs have coagulopathy, thrombocytopenia, liver disease, or hematologic malignancies, raising concerns about bleeding risk. The true incidence of hemorrhagic complications and the value of preventive measures in these populations remain uncertain.

The objective of this study is to systematically evaluate the incidence of bleeding related to CVC placement in adults at increased hemorrhagic risk and to assess the effectiveness of periprocedural preventive strategies.

PubMed, Embase, Cochrane Library, and Web of Science were searched from January 2000 to March 2025. Randomized trials and observational studies involving adults with elevated bleeding risk undergoing CVC placement were included. Data extraction and risk of bias assessment (RoB 2 and Newcastle–Ottawa Scale) were performed independently by two reviewers. Certainty of evidence was rated using GRADE (Grading of Recommendations Assessment, Development, and Evaluation), and random-effects meta-analyses were conducted when appropriate.

Forty-one studies encompassing 7,603 patients and 8,796 CVC insertions were analyzed. Major bleeding occurred in 0.57% of procedures and minor bleeding in 8.1%. The pooled incidence of any bleeding across 22 studies was 6.8% (95% confidence interval, 3.7–10.7%). Bleeding was more frequent among patients with hematologic malignancies, severe thrombocytopenia, or critical illness. Ultrasound guidance markedly reduced complications compared with landmark technique. Platelet transfusion was effective only below 30 × 10
9
/L, whereas fresh-frozen plasma showed no clear benefit.

CVC placement in adults with coagulopathy or thrombocytopenia is generally safe. Ultrasound guidance, restrictive transfusion thresholds, and thromboelastography-guided assessment enhance procedural safety and reduce unnecessary transfusions.

## Linked entities

- **Diseases:** coagulopathy (MONDO:0001531), thrombocytopenia (MONDO:0002049), liver disease (MONDO:0005154)

## Full-text entities

- **Diseases:** liver disease (MESH:D008107), coagulopathy (MESH:D001778), critical illness (MESH:D016638), thrombocytopenia (MESH:D013921), Bleeding (MESH:D006470), hematologic malignancies (MESH:D019337)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12757087/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12757087/full.md

## References

65 references — full list in the complete paper: https://tomesphere.com/paper/PMC12757087/full.md

---
Source: https://tomesphere.com/paper/PMC12757087